A new trading day began on Tuesday, with RxSight Inc (NASDAQ: RXST) stock price down -4.97% from the previous day of trading, before settling in for the closing price of $45.84. RXST’s price has ranged from $29.97 to $66.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 48.48%. With a float of $38.24 million, this company’s outstanding shares have now reached $40.25 million.
Let’s look at the performance matrix of the company that is accounted for 374 employees. In terms of profitability, gross margin is 63.45%, operating margin of -28.24%, and the pretax margin is -22.17%.
RxSight Inc (RXST) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The most recent insider transaction that took place on Nov 29 ’24, was worth 143,078. In this transaction an insider of this company sold 3,105 shares at a rate of $46.08, taking the stock ownership to the 42,246 shares. Before that another transaction happened on Nov 29 ’24, when Company’s Officer proposed sale 3,105 for $46.08, making the entire transaction worth $143,078.
RxSight Inc (RXST) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 48.48% per share during the next fiscal year.
RxSight Inc (NASDAQ: RXST) Trading Performance Indicators
Here are RxSight Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of RxSight Inc (RXST)
RxSight Inc (NASDAQ: RXST) saw its 5-day average volume 0.36 million, a negative change from its year-to-date volume of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 42.47%. Additionally, its Average True Range was 2.01.
During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 29.06%, which indicates a significant increase from 5.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.30% in the past 14 days, which was lower than the 47.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $48.41, while its 200-day Moving Average is $52.58. Nevertheless, the first resistance level for the watch stands at $45.33 in the near term. At $47.11, the stock is likely to face the second major resistance level. The third major resistance level sits at $48.12. If the price goes on to break the first support level at $42.54, it is likely to go to the next support level at $41.53. The third support level lies at $39.75 if the price breaches the second support level.
RxSight Inc (NASDAQ: RXST) Key Stats
With a market capitalization of 1.76 billion, the company has a total of 40,304K Shares Outstanding. Currently, annual sales are 89,080 K while annual income is -48,610 K. The company’s previous quarter sales were 35,310 K while its latest quarter income was -6,340 K.
